39.94p-0.06 (-0.15%)19 Mar 2024, 13:04
Jump to:
Futura Medical PLC Fundamentals
Company Name | Futura Medical PLC | Last Updated | 2024-03-19 |
---|---|---|---|
Industry | Biotechnology | Sector | Healthcare |
Shares in Issue | 301.449 m | Market Cap | £120.40 m |
PE Ratio | 0.00 | Dividend per Share | 0 |
Dividend Yield | 0 | Dividend Cover | 0 |
EPS | -£0.02 | EPS Growth (%) | 0 |
PEG | 0 | DPS Growth (%) | 0 |
Debt Ratio | 0 | Debt Equity Ratio | 0 |
Asset Equity Ratio | 1.2740 | Cash Equity Ratio | 0.9784 |
Quick Ratio | 4.0286 | Current Ratio | 4.15 |
Price To Book Value | 15.0602 | ROCE | 0 |
Futura Medical PLC Dividends
Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
---|
Futura Medical PLC Company Financials
Assets | 2022 | 2021 |
---|---|---|
Tangible Assets | £1.16 m | £442,657.00 |
Intangible Assets | 0 | 0 |
Investments | 0 | 0 |
Total Fixed Assets | £1.16 m | £442,657.00 |
Stocks | 0 | 0 |
Debtors | £70,114.00 | £7,547.00 |
Cash & Equivalents | £4.03 m | £10.37 m |
Other Assets | 0 | 0 |
Total Assets | £6.47 m | £11.80 m |
Liabilities | 2022 | 2021 |
---|---|---|
Creditors within 1 year | £1.75 m | £2.08 m |
Creditors after 1 year | 0 | 0 |
Other Liabilities | 0 | 0 |
Total Liabilities | £1.75 m | £2.08 m |
Net assets | £4.72 m | £9.72 m |
Equity | 2022 | 2021 |
---|---|---|
Called up share capital | £576,093.00 | £574,302.00 |
Share Premium | £66.55 m | £66.38 m |
Profit / Loss | -£6.87 m | -£5.87 m |
Other Equity | £4.72 m | £9.72 m |
Preference & Minorities | 0 | 0 |
Total Capital Employed | £4.72 m | £9.72 m |
Ratios | 2022 | 2021 |
---|---|---|
Debt Ratio | 0 | 0 |
Debt-to-Equity | 0 | 0 |
Assets / Equity | 1.2740 | 1.2740 |
Cash / Equity | 0.9784 | 0.9784 |
EPS | -£0.02 | -£0.02 |
Cash Flow | 2022 | 2021 |
---|---|---|
Cash from operating activities | -£5.78 m | -£3.87 m |
Cashflow before financing | -£5.61 m | £9.77 m |
Increase in Cash | -£6.35 m | £9.35 m |
Income | 2022 | 2021 |
---|---|---|
Turnover | 0 | 0 |
Cost of sales | 0 | 0 |
Gross Profit | 0 | 0 |
Operating Profit | -£6.87 m | -£5.87 m |
Pre-Tax profit | -£6.87 m | -£5.87 m |
Futura Medical PLC Company Background
Sector | Healthcare |
---|---|
Activities | Futura Medical PLC is a pharmaceutical company based on technology. The company manufactures drugs and is based in the United Kingdom. The company lays primary focus on topically applied pharmaceutical drugs and medical devices which are developed using a efficient and proprietary transdermal delivery technology, DermaSys. DermaSys is a versatile technology that can be customized to suit the specific active compound being used and the therapeutic indication. The company's products are used mainly for the treatment of erectile dysfunction and pain relief. |
Latest Interim Date | 18 Sep 2023 |
Latest Fiscal Year End Date | 5 Apr 2023 |
Futura Medical PLC Directors
Appointed | Name | Position |
---|---|---|
2024-01-17 | Mr. Jeffrey Robert Needham | Executive Director,Chairman |
2023-07-18 | Mr. John Milne Clarke | Non-Executive Director,Chairman |
2016-03-31 | Ms. Lisa Arnold | Non-Executive Director |
2012-02-01 | Dr. William Duncan Potter | Executive Director,Chairman |
2024-01-17 | Mr. Andrew Vaughan Unitt | Non-Executive Director,Senior Independent Director |
2024-01-17 | Mr. James Henry Barder | Executive Director,Chief Executive |
2021-12-29 | Mr. Jonathan David Freeman | Non-Executive Director,Senior Independent Director |
2015-03-28 | Mr. David Bryn Davies | Executive Director,Chief Development Officer |
2018-04-09 | Mr. Derek Adrian Martin | Executive Director,Finance Director and Company Secretary |
2011-08-09 | Mr. Anthony Louis Clayden BSc,FCA,MSI | Executive Director,Finance Director and Company Secretary |
2023-10-10 | Mr. Kenneth William James | Executive Director,Head of RandD |
2023-10-10 | Ms. Angela Hildreth | Executive Director,Finance Director, Chief Operating Officer and Company Secretary |
Futura Medical PLC Contact Details
Company Name | Futura Medical PLC |
---|---|
Address | 40 Occam Road, Surrey Technology Centre, Guildford, GU2 7YG |
Telephone | +44 1483685670 |
Website | https://www.futuramedical.com |
Futura Medical PLC Advisors
Auditor | KPMG |
---|---|
Phone | +44 1189642000 |
Fax | +44 1189642222 |
Bank | HSBC Bank PLC |
---|
Solicitor | Withers & Rogers LLP |
---|---|
Phone | +44 2079403600 |
Fax | +44 2073789680 |
Stockbroker | N+1 Singer |
---|---|
Phone | +44 2074963000 |
Fax | +44 2074963150 |
Nominated Adviser | N+1 Singer |
---|---|
Phone | +44 2074963000 |
Fax | +44 2074963150 |
Registrar | Capita Asset Services |
---|---|
Phone | +44 8716640300 |
Fax | +44 2086392342 |
Financial PR Adviser | Buchanan |
---|---|
Phone | +44 2074665000 |
Fax | +44 2074665001 |
Solicitor | Memery Crystal |
---|---|
Phone | +44 2072425905 |
Fax | +44 2072422058 |
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
Company | Price | % Chg |
---|---|---|
Close Brothers Group PLC | 365.20 | 9.28 |
Puretech Health PLC | 222.00 | 8.82 |
W.A.G Payment Solutions PLC | 78.00 | 8.33 |
Unilever PLC | 3,932.50 | 3.17 |
Tp Icap Group PLC | 222.40 | 2.49 |
Bytes Technology Group PLC | 537.50 | 2.48 |
Fallers
Company | Price | % Chg |
---|---|---|
Crest Nicholson Holdings PLC | 197.90 | -11.65 |
Essentra PLC | 164.60 | -5.18 |
Diversified Energy Company PLC | 876.50 | -5.09 |
Reckitt Benckiser Group PLC | 4,398.00 | -3.87 |
Fresnillo PLC | 445.50 | -3.40 |
Octopus Renewables Infrastructure Trust PLC | 75.80 | -3.07 |